What is Bioperfectus diagnostic strategy under new SARS-CoV-2 variants?


On May 31st, WHO announced simple, easy-to-say labels for SARS-CoV-2 Variants of Interest and Concern. Since the outbreak of SARS-CoV-2, genetic variants of SARS-CoV-2 have been emerging and circulating globally. These variants can be very transmissible and have potential to increase hospitalizations and fatality rates.

In face of SARS-CoV-2 variants, what is our diagnostic strategy?

Bioperfectus, as a pioneering infectious disease diagnostic solution provider in the globe, has been studying the characteristics of the SARS-CoV-2 variants and working on developing most effective, efficient and accessible diagnostic solutions to combat COVID-19 pandemic.

Under the investigation of Bioperfectus R&D team, we hereby conclude that Bioperfectus COVID-19 Coronavirus Real Time PCR Kit, COVID-19 Coronavirus (ORF1ab/N/E) Real Time PCR Kit and COVID-19 Coronavirus and Influenza A/B Virus Real Time PCR Kit are confirmed to stay effective and free from the impact of the listed SARS-CoV-2 variants below: